Twist Bioscience Corp Quarterly Cost of Revenue in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Twist Bioscience Corp quarterly/annual Cost of Revenue history and growth rate from Q4 2017 to Q3 2024.
  • Twist Bioscience Corp Cost of Revenue for the quarter ending September 30, 2024 was $46.5M, a 9.55% increase year-over-year.
  • Twist Bioscience Corp Cost of Revenue for the twelve months ending September 30, 2024 was $180M, a 15.6% increase year-over-year.
  • Twist Bioscience Corp annual Cost of Revenue for 2024 was $180M, a 15.6% increase from 2023.
  • Twist Bioscience Corp annual Cost of Revenue for 2023 was $155M, a 30.2% increase from 2022.
  • Twist Bioscience Corp annual Cost of Revenue for 2022 was $119M, a 48% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $180M $46.5M +$4.05M +9.55% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-18
Q2 2024 $176M $46.2M +$4.35M +10.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $171M $44.4M +$2.75M +6.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $168M $42.5M +$13.1M +44.5% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-02
Q3 2023 $155M $42.4M +$10.8M +34.3% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-18
Q2 2023 $145M $41.8M +$10.9M +35.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $134M $41.7M +$12M +40.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $122M $29.4M +$2.39M +8.82% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 $119M $31.6M +$9.09M +40.4% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-18
Q2 2022 $110M $31M +$10M +48% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $100M $29.7M +$10.7M +56.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $89.5M $27.1M +$8.89M +49% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $80.6M $22.5M +$4.92M +28% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-21
Q2 2021 $75.7M $20.9M +$4.46M +27.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $71.2M $19M +$5.46M +40.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $65.8M $18.2M +$4.37M +31.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $61.4M $17.6M +$5.19M +41.9% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-06-05
Q2 2020 $56.2M $16.5M +$5.08M +44.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $51.1M $13.6M +$1.78M +15.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $49.4M $13.8M +$1.94M +16.3% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $47.4M $12.4M +$3.29M +36.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 $44.1M $11.4M +$3.89M +51.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $40.2M $11.8M +$3.69M +45.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $36.5M $11.9M +$4.36M +58.1% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 $32.2M $9.09M Jul 1, 2018 Sep 30, 2018 10-K 2020-11-27
Q2 2018 $7.5M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $8.1M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $7.5M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.